Related Experiment Video

Updated: May 3, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

12.4K

A small molecule, MTBT, prevents cancer cell growth by activating p38 MAPK

Yan Li1, Xuelian Zhang, Jing Zhang

  • 1aInstitute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, People's Republic of China bDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, Florida, USA.

Anti-Cancer Drugs
|January 21, 2014
PubMed

Insights

Researchers discovered a new compound, 2-(3-methyl-thiophen-2-yl)-4-(3,4-dioxybenzene) thiazole (MTBT), that halts cancer cell division and triggers apoptosis. This novel anticancer agent functions by activating the p38 mitogen-activated protein kinase pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer is characterized by uncontrolled cell division, making the cell cycle a key target for anticancer therapies.
  • Developing novel drugs that effectively inhibit cancer cell proliferation remains a critical challenge in oncology.

Purpose of the Study:

  • To identify novel small compounds that induce cell cycle arrest in cancer cells.
  • To elucidate the mechanism of action of a newly identified compound, MTBT, in inhibiting cancer cell proliferation.

Main Methods:

  • A small compound library was screened to identify agents inducing cell cycle arrest.
  • Cancer cell lines were treated with the identified compound (MTBT) to assess its effects on cell cycle progression, DNA content, colony formation, and apoptosis.
  • Western blotting was used to analyze histone H3 (Ser10) phosphorylation and p38 mitogen-activated protein kinase (MAPK) activation.
  • The role of p38 MAPK in MTBT's effects was investigated using a specific inhibitor (SB203580).

Main Results:

  • The compound 2-(3-methyl-thiophen-2-yl)-4-(3,4-dioxybenzene) thiazole (MTBT) was identified, causing cancer cells to accumulate with 4N DNA content and inhibiting colony formation.
  • MTBT treatment led to apoptosis, evidenced by a sub-G1 DNA peak and apoptotic markers, and induced M-phase cell cycle arrest, indicated by increased histone H3 (Ser10) phosphorylation.
  • MTBT treatment activated the p38 MAPK pathway, as shown by increased p38 phosphorylation. This activation was crucial, as p38 inhibition abrogated MTBT-induced cell cycle arrest and H3 (Ser10) phosphorylation.

Conclusions:

  • MTBT is a novel compound that effectively inhibits cancer cell proliferation and induces apoptosis.
  • The anticancer effects of MTBT are mediated through the activation of the p38 MAPK signaling pathway, leading to cell cycle arrest.
  • MTBT represents a promising candidate for further development as an anticancer therapeutic agent targeting cell cycle regulation.

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.2K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K